Moleculin Biotech Inc (MBRX)

[cvinvestor]

Those hoping for $3.00 can close their books. No BIG news. Call just ended and this will go where those who don't want to hold will send it.

In spite of $22M in cash, which they expect will last until data comes out later this year, more cash will be needed. The 1.60 9.3M sales was an opportunity that presented itself and I think they did an excellent job in capitalizing on it, but this won't rocket anywhere but down tomorrow, if it goes anywhere since there is no new news to speak of.

Put all the PRs together and company has gone from 1 clinical trial to 4 and potential 5th later this year.

The most significant factor stated in CC is that they expect to report trial data every Qtr going forward because of the various trials ongoing right now. However, note that CEO also stated, the faster the trials go in enrollment, the greater the spend in their R&D and the sooner they will need more capital. The good news from that is that he projects good trial data will bring in more discussions of potential partners, but there is no golden egg about to be laid.

This is an excellent LT play based on what was said in CC and there will be ST plays on trial data news, but I don't see this going anywhere near $3.00 in the ST.

All is opinion based on the expectations around this CC and what was said on the call, to which I listened.